Literature DB >> 25845488

Analysis of quality improvement efforts in preventing glucocorticoid-induced osteoporosis.

Heather O Tory1, Daniel H Solomon2, Sonali P Desai3.   

Abstract

OBJECTIVE: To report and analyze quality improvement (QI) efforts that are aimed at increasing adherence to preventive guidelines for glucocorticoid-induced osteoporosis (GIOP).
METHODS: We performed a PubMed literature search for full-length articles in English between 1966 and 2013, describing approaches for improving the quality of GIOP care. We reviewed articles using a structured approach and abstracted information on the patient population, study design, QI intervention, and primary outcome measures. A descriptive analysis was then performed.
RESULTS: Literature search identified 661 articles; 38 were screened by abstract, 10 were identified for full review, and 7 were included. Two non-randomized, uncontrolled studies of system changes showed significant improvements in GIOP prevention: one increased concomitant prescriptions of glucocorticoids and calcium (37-49%, p < 0.0001) and vitamin D (38-53%, p < 0.0001) using a computerized order entry system; another used a dedicated clinical team to increase vitamin D levels from 19.5 to 29.4 (p = 0.001) and improve GIOP-related habits. Five articles described education-based interventions, including 3 randomized controlled trials (RCTs). Two non-significant RCTs focused on physicians, but one directed towards pharmacists and patients did increase calcium supplementation in the intervention vs. control arm (55.7% vs. 31.6%, p < 0.05). Two other non-randomized educational interventions did not show benefits. Comparison of articles was limited by the heterogeneity of the intervention methods and outcome measures used.
CONCLUSION: None of the interventions produced robust changes, with overall adherence to GIOP guidelines remaining low. System-based interventions appeared more effective than education-based interventions, but a diverse array of factors likely needs to be addressed, requiring more randomized controlled trials and greater standardization of outcome measures.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Glucocorticoids; Osteoporosis; Quality of care

Mesh:

Substances:

Year:  2015        PMID: 25845488     DOI: 10.1016/j.semarthrit.2014.09.011

Source DB:  PubMed          Journal:  Semin Arthritis Rheum        ISSN: 0049-0172            Impact factor:   5.532


  4 in total

1.  Glucocorticoid-induced osteoporosis: pathophysiological role of GH/IGF-I and PTH/VITAMIN D axes, treatment options and guidelines.

Authors:  Gherardo Mazziotti; Anna Maria Formenti; Robert A Adler; John P Bilezikian; Ashley Grossman; Emilia Sbardella; Salvatore Minisola; Andrea Giustina
Journal:  Endocrine       Date:  2016-10-20       Impact factor: 3.633

Review 2.  Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.

Authors:  Michaël R Laurent; Stefan Goemaere; Charlotte Verroken; Pierre Bergmann; Jean-Jacques Body; Olivier Bruyère; Etienne Cavalier; Serge Rozenberg; Bruno Lapauw; Evelien Gielen
Journal:  Front Endocrinol (Lausanne)       Date:  2022-06-09       Impact factor: 6.055

Review 3.  Behavior change interventions and policies influencing primary healthcare professionals' practice-an overview of reviews.

Authors:  Bhupendrasinh F Chauhan; Maya M Jeyaraman; Amrinder Singh Mann; Justin Lys; Becky Skidmore; Kathryn M Sibley; Ahmed M Abou-Setta; Ryan Zarychanski
Journal:  Implement Sci       Date:  2017-01-05       Impact factor: 7.327

4.  Preventive effects of Polygonum multiflorum on glucocorticoid-induced osteoporosis in rats.

Authors:  Manru Zhou; Jin Li; Jingkai Wu; Yajun Yang; Xiaobing Zeng; Xiaohua Lv; Liao Cui; Weimin Yao; Yuyu Liu
Journal:  Exp Ther Med       Date:  2017-07-18       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.